Lasers for Onychomycosis

Aditya K Gupta1,2, Kelly A Foley2, Sarah G Versteeg2

  • 11 Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Insights

Laser treatment for fungal nail infections (onychomycosis) temporarily improves nail appearance but is not a cure. Future studies need consistent FDA guidelines for reliable efficacy data.

Area of Science:

  • Dermatology
  • Medical Device Technology

Background:

  • Onychomycosis is a common fungal nail infection.
  • Laser treatment is FDA-approved for temporary improvement in clear nail growth.
  • Patients often misunderstand that laser therapy is not a cure for onychomycosis.

Purpose of the Study:

  • To review the theoretical basis for laser efficacy in onychomycosis.
  • To critically evaluate published laser treatment studies against drug trial standards.
  • To highlight inconsistencies in current research and propose improvements.

Main Methods:

  • Literature review of laser treatment studies for onychomycosis.
  • Comparative analysis of study methodologies against US Food and Drug Administration (FDA) guidelines for medical devices.
  • Assessment of reported efficacy endpoints and units of analysis.

Main Results:

  • Published laser studies exhibit significant variability in treatment regimens, efficacy endpoints, and units of analysis (nails vs. patients).
  • Rates of complete cure, mycological cure, and clinical improvement are inconsistently reported, precluding meaningful comparison between studies.
  • Current research does not consistently adhere to established standards for clinical trial design in onychomycosis.

Conclusions:

  • Laser treatment offers temporary nail clearance for onychomycosis, not a definitive cure.
  • Inconsistent methodologies and reporting in current studies hinder the evaluation of laser efficacy.
  • Future research must adopt FDA guidelines for medical device trials to ensure consistency and reliable data on laser monotherapy for onychomycosis.